The US Food and Drug Administration has approved the use of a novel painkiller as an effective treatment for short-term ...
The FDA’s approval for expanded use reinforces LP-310’s potential as a new therapeutic option for OLP and supports ongoing clinical development efforts.
Susvimo is also approved for wet age-related macular degeneration. The FDA approved Susvimo for the treatment of diabetic macular edema, according to a press release. The decision was supported by ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results